Venture capital. Examined.
8 companies in Arch Venture Partners's investment portfolio.
“Invests at the frontier of science and technology, backing breakthrough discoveries with the potential to transform healthcare and computing.”
Clinical-stage biotech developing cancer treatments by controlling gene expression using proprietary gene control platforms.
